Lab for Clinical & Integrative Neuroscience




The Lab for Clinical and Integrative Neuroscience (Lab CLINT) is part of Trinity College Institute for Neuroscience at Trinity College Dublin. Lab CLINT aims to advance fundamental knowledge of human brain function and to use this knowledge to help people with psychiatric and neurological disorders. Our research integrates multimodal brain imaging techniques with novel invasive and non-invasive neuromodulation techniques to determine mechanisms underlying neuroplasticity dysfunction. More specifically, we work to understand the mechanisms of (mal)adaptive plasticity and develop new treatment approaches for different neurological (pain, tinnitus, Parkinson's disease, cognitive impairment) and psychiatric diseases (addiction, OCD, depression).


More information


Meet the Lab CLINT team.


Journal articles, Book Chapter and Books


Current Research Interests


TRI Academy - Online Seminar Series



The Tinnitus Research Initiative launches its TRI Academy online seminar series. The first seminar will be on September 15, 2021, 12:00 - 13:00 CEST and will be organised every third Wednesday of the month. Each seminar contains of two approximately 20-minute presentations that covers different topics related to tinnitus inclduing definition, risk factors and prevalence, tinnitus mechanisms, treatment options, evidence-based and alternative medicine, e-health and Big Data, and more.


More information can be found on the TRI website





TRI 2023





The 13th Annual Tinnitus Research Initiative (TRI) Conference will take place at Trinity College Dublin, Ireland from June 7 to 10, 2023. Over the years, the annual TRI conference has attracted scientists, physicians, healthcare professionals and industrialists to influence the tinnitus field. This year we envision a unique and historical extension of this gathering to tinnitus patients and caregivers, inviting them to significantly contribute to shaping the field for the generations to come.

While tinnitus is a common symptom, current-day treatments reduce the impact than specifically address the percept itself. Globally, tinnitus sufferers demand a permanent solution to this problem. Although market research demonstrates a strong commercial opportunity, the amount of scientific research and financial investment is small compared to other chronic health conditions. TRI 2023 aims to bring together world-class scientists, industrialists, clinicians and policymakers, patients and caregivers to address these impending issues thereby seeking to bridge the gap between academia, industry, medicine & society (AIMS).


Progress in Brain Research series



Interested in tinnitus research? The progress in brain research series provides insights into genetic and epidemiological research on tinnitus, etiologic and risk factors as well as comorbidities, and findings from structural and functional neuroimaging and particularly about tinnitus related alterations of oscillatory brain function, as well as pathophysiological models, both simulations, cellular and macroscopic approaches. Furthermore, heterogeneity of tinnitus is addressed by focusing on co-morbidities of tinnitus, profiling of tinnitus patients, analyses of large clinical databases, subtyping approaches and individualized treatment.


Read more: Vol. 260 Vol. 262 Vol. 263